Klebsiella pneumoniae Sepsis – A Complete Patient Guide

Overview

Klebsiella pneumoniae is a gram‑negative, rod‑shaped bacterium that normally lives in the gastrointestinal tract, mouth, and skin of healthy people. When it enters sterile body sites (blood, lungs, urinary tract, or wounds) it can cause serious infections, the most severe being **sepsis** — a dysregulated immune response to infection that can lead to organ failure and death.

• Who it affects: Adults of any age can develop Klebsiella sepsis, but the highest rates are seen in:
  • Older adults (≥65 years)
  • People with weakened immune systems (e.g., chemotherapy, HIV, organ transplant)
  • Patients with chronic diseases such as diabetes, liver cirrhosis, or chronic lung disease
  • Individuals who have recently been hospitalized, especially those with invasive devices (catheters, ventilators)
• Prevalence: In the United States, Klebsiella spp. cause ~10 % of all hospital‑acquired bloodstream infections. Worldwide, Klebsiella pneumoniae is the 5th most common cause of sepsis in intensive‑care units, accounting for an estimated 150,000–200,000 deaths each year.^[1][2]
• Why it matters: Some strains produce extended‑spectrum β‑lactamases (ESBL) or carbapenemases, making them resistant to many antibiotics. Multidrug‑resistant (MDR) Klebsiella sepsis carries a mortality rate of 30‑50 % compared with 15‑20 % for susceptible strains.^[3]

Symptoms

Sepsis is a systemic response, so symptoms reflect both infection and organ‑dysfunction. The classic “sepsis triad” includes fever, rapid heart rate, and rapid breathing, but presentation can be subtle, especially in the elderly.

Early systemic signs

• Fever ≥38 °C (100.4 °F) or hypothermia (<36 °C/96.8 °F)
• Chills or rigors
• Feeling “flu‑like” or extremely fatigued
• Generalized weakness

Cardiovascular / Respiratory

• Rapid heartbeat (tachycardia > 90 bpm)
• Low blood pressure (systolic < 100 mm Hg) or a sudden drop from baseline
• Shortness of breath, rapid breathing (tachypnea > 20 breaths/min)
• New or worsening cough, possibly with sputum that is green or bloody (if the source is pneumonia)

Neurologic

• Confusion, disorientation, or altered mental status
• Agitation or lethargy

Renal / Gastrointestinal

• Decreased urine output (oliguria)
• Abdominal pain or tenderness (if the source is intra‑abdominal)
• Nausea, vomiting, or diarrhea

Skin

• Rash, especially petechiae or purpura
• Redness, swelling, or drainage at a wound or catheter site

Because the signs can overlap with other illnesses, any combination of these symptoms in a person with a possible infection source should prompt urgent evaluation.

Causes and Risk Factors

How infection occurs

Klebsiella pneumoniae can reach the bloodstream through several pathways:

1. Respiratory tract: Aspiration of oropharyngeal secretions, particularly in patients on ventilators or with chronic lung disease.
2. Urinary tract: Colonization of urinary catheters or instrumentation.
3. Intra‑abdominal: Perforated bowel, pancreatitis, or postoperative intra‑abdominal infections.
4. Skin/soft‑tissue: Surgical wounds, burns, or diabetic foot ulcers.
5. Bloodstream devices: Central venous catheters or peripherally inserted central catheters (PICCs).

Key risk factors

• Recent hospitalization (especially ICU stay)
• Broad‑spectrum antibiotic use (selects for resistant strains)
• Immunosuppression (corticosteroids, chemotherapy, HIV/AIDS)
• Chronic diseases: diabetes mellitus, chronic kidney disease, liver cirrhosis
• Structural lung disease (COPD, bronchiectasis)
• Invasive devices: urinary catheters, endotracheal tubes, feeding tubes
• Long‑term care facility residence
• Travel or healthcare exposure in regions with high MDR Klebsiella prevalence (e.g., South Asia, parts of Europe)

Diagnosis

Prompt diagnosis hinges on clinical suspicion and rapid laboratory testing.

Initial clinical assessment

• Full history (recent procedures, device use, antibiotic exposure)
• Physical exam focusing on infection source and organ dysfunction
• Calculate the qSOFA score (respiratory rate ≥ 22, altered mentation, systolic BP ≤ 100 mm Hg). A score ≥ 2 suggests high sepsis risk.

Laboratory and imaging studies

1. Blood cultures: Obtain at least two sets (aerobic & anaerobic) **before** starting antibiotics. Positive cultures within 24–48 hours confirm bacteremia.
2. Complete blood count (CBC): Leukocytosis (>12,000 cells/µL) or leukopenia (<4,000 cells/µL) can occur.
3. Serum lactate: Levels ≥ 2 mmol/L indicate tissue hypoperfusion and are a marker of severity.
4. C‑reactive protein (CRP) / Procalcitonin: Elevated values support bacterial infection.
5. Renal & hepatic panels: Assess organ function for dosing antibiotics.
6. Urinalysis & urine culture: If urinary source is suspected.
7. Chest X‑ray / CT scan: Look for pneumonia, effusions, or abscesses.
8. Source‑specific imaging: Abdominal CT, ultrasound, or MRI when intra‑abdominal infection is possible.
9. Antibiotic susceptibility testing: Once Klebsiella is isolated, labs determine if the strain is ESBL‑producing or carbapenem‑resistant.

Diagnostic criteria

Sepsis is defined by the 2016 Sepsis‑3 criteria: life‑threatening organ dysfunction caused by a dysregulated host response to infection. In practice, this is identified by a rise in the SOFA (Sequential Organ Failure Assessment) score of ≥ 2 points from baseline, together with a confirmed or suspected infection.

Treatment Options

Treatment integrates rapid antimicrobial therapy, source control, and supportive care.

Empiric antibiotic therapy

Start within the first hour of recognition. Choice depends on local resistance patterns and patient risk factors.

• Low‑risk, community‑onset infection:
  • Third‑generation cephalosporin (e.g., ceftriaxone 2 g IV daily) + metronidazole if anaerobes are possible.
• High‑risk or healthcare‑associated infection (possible ESBL):
  • Carbapenem (e.g., meropenem 1 g IV q8h) is the preferred initial agent.
• Known carbapenem‑resistant Klebsiens (CRKP):
  • Combination therapy such as ceftazidime‑avibactam + aztreonam, or polymyxins (colistin) + tigecycline, guided by susceptibility reports.

De‑escalate to the narrowest effective drug once culture results return.

Source control

• Drain abscesses or empyemas surgically or percutaneously.
• Remove or replace infected catheters, lines, or prosthetic devices.
• Address obstructive uropathy or biliary blockage.

Supportive care

1. Fluid resuscitation: 30 mL/kg crystalloid bolus (e.g., normal saline or lactated Ringer’s) within the first 3 hours; adjust based on MAP (target ≥ 65 mm Hg).
2. Vasopressors: Norepinephrine first‑line if hypotension persists after fluids.
3. Respiratory support: Supplemental O₂, high‑flow nasal cannula, or mechanical ventilation as needed.
4. Renal replacement therapy: Consider for acute kidney injury with oliguria or metabolic derangements.
5. Glucose control: Maintain blood glucose 140‑180 mg/dL (avoid hypoglycemia).
6. Stress‑dose steroids: Hydrocortisone 200 mg/day may be added in refractory shock per Surviving Sepsis Guidelines.

Adjunctive measures

• Prophylactic anti‑coagulants (low‑dose heparin) to reduce venous thromboembolism risk.
• Daily sedation interruption and early mobilization for mechanically ventilated patients.
• Nutrition: enteral feeding preferred within 24‑48 h if feasible.

Duration of therapy

Typical courses range from 10–14 days for uncomplicated bacteremia, extending to 4–6 weeks for deep‑seated infections (e.g., endovascular, osteomyelitis). Always tailor duration to clinical response and repeat cultures.

Living with Klebsiella pneumoniae Sepsis

Post‑discharge considerations

• Follow‑up appointments: Within 1‑2 weeks to review labs, repeat blood cultures, and assess organ function.
• Medication adherence: Complete the full antibiotic course; set alarms or use pillboxes.
• Rehabilitation: Physical therapy to regain strength after ICU stay.
• Vaccinations: Keep influenza and pneumococcal vaccines up to date; these reduce future respiratory infections.

Self‑monitoring tips

Maintain a daily log of:

• Temperature, heart rate, blood pressure
• Urine output and color
• New or worsening pain, shortness of breath, or confusion
• Any wound drainage or catheter site redness

Report any concerning changes to your health‑care provider promptly.

Psychological health

Survivors of sepsis often experience anxiety, depression, or post‑traumatic stress. Seek counseling, support groups, or a mental‑health professional if you notice persistent low mood, sleep disturbances, or intrusive memories.

Prevention

In the health‑care setting

• Strict hand‑hand hygiene (alcohol‑based rubs or soap and water).
• Careful insertion and maintenance of central lines, urinary catheters, and ventilators – remove them as soon as they are no longer needed.
• Antibiotic stewardship: Use narrow‑spectrum agents when possible to limit resistance.
• Screening and isolation of patients colonized with MDR Klebsiella in high‑risk units.

At home

• Wash hands thoroughly before handling wounds, catheters, or feeding tubes.
• Maintain good oral hygiene to reduce bacterial load.
• Stay current with vaccines (influenza, COVID‑19, pneumococcal).
• Control chronic conditions – especially diabetes (target HbA1c < 7 %).
• Avoid unnecessary antibiotics; discuss any prescription with your clinician.

Complications

If sepsis is not promptly treated, Klebsiella pneumoniae can lead to:

• Septic shock: Persistent hypotension despite fluids, high mortality.
• Acute respiratory distress syndrome (ARDS): Severe lung injury requiring mechanical ventilation.
• Acute kidney injury (AKI): May need dialysis.
• Disseminated intravascular coagulation (DIC): Abnormal clotting and bleeding.
• Endocarditis: Infection of heart valves, potentially causing heart failure.
• Metastatic abscesses: Spread to liver, brain, or bones.
• Long‑term functional decline: Muscle weakness, cognitive impairment, reduced quality of life.

When to Seek Emergency Care

---

Sources: [1] CDC, “Antibiotic Resistance Threats in the United States, 2019.” [2] WHO, “Global Report on Sepsis, 2022.” [3] Lee, J. et al., “Outcomes of Carbapenem‑Resistant Klebsiella pneumoniae Bacteremia,” *Clinical Infectious Diseases*, 2021. Mayo Clinic, “Sepsis,” accessed May 2026. Cleveland Clinic, “Klebsiella Infection,” accessed May 2026.